Table 1.
Demographic and angiographic characteristics of patients in non-remodelling (NR) and remodelling (R) groups
| Variable | NR group (n = 25) | R group (n = 20) | p Value |
| Age (years) | 62 (9) | 63 (9) | NS |
| Men | 23 (92%) | 15 (75%) | NS |
| Time to reperfusion after onset of infarction (hours) | 12.6 (16.3) | 18.3 (23.3) | NS |
| Systemic hypertension | 5 (20%) | 5 (25%) | NS |
| Diabetes mellitus | 7 (28%) | 1 (5%) | NS |
| Hyperlipidaemia* | 14 (56%) | 14 (70%) | NS |
| Medications | |||
| ACE inhibitors | 12 (48%) | 17 (85%) | <0.05 |
| Nitrates | 20 (80%) | 12 (60%) | NS |
| Calcium channel antagonists | 6 (24%) | 6 (30%) | NS |
| Diuretics | 2 (8%) | 9 (45%) | <0.05 |
| β Blockers | 3 (12%) | 0 (0%) | NS |
| Antiplatelet agents | 25 (100%) | 20 (100%) | NS |
| Angiographic characteristics | |||
| Coronary arteries with >75% narrowing | NS | ||
| 0 | 7 (28%) | 6 (30%) | |
| 1 | 13 (52%) | 8 (40%) | |
| 2 | 4 (16%) | 5 (25%) | |
| 3 | 1 (4%) | 1 (5%) | |
| Defect volume (arbitrary units) | 938 (708) | 1385 (832) | NS |
Data are mean (SD) or number (%).
*Defined as serum total cholesterol concentration >5.69 mmol/l or triglycerides >1.95 mmol/l.
ACE, angiotensin converting enzyme; NS, not significant.